1,2-Distearoyl-sn-glycero-3-phosphoethanolamine

1,2-Distearoyl-sn-glycero-3-phosphoethanolamine is a lipid of Glycerophospholipids (GP) class. 1,2-distearoyl-sn-glycero-3-phosphoethanolamine is associated with abnormalities such as Painful Bladder Syndrome, Dehydration, Renal tubular disorder, Gigantism and Tumor-Associated Vasculature. The involved functions are known as conjugation, Ligand Binding, Process, Laser-generated electromagnetic radiation and Blood Circulation. 1,2-distearoyl-sn-glycero-3-phosphoethanolamine often locates in Tissue membrane, Early endosome, Body tissue, Cell surface and Membrane. The associated genes with 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine are R peptide, P4HTM gene, NHS gene, TSPO gene and SLC33A1 gene. The related lipids are Liposomes, 1,2-distearoylphosphatidylethanolamine, Micelles, Fatty Acids and sialogangliosides.

Cross Reference

Introduction

To understand associated biological information of 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine?

1,2-Distearoyl-sn-glycero-3-phosphoethanolamine is suspected in Renal tubular disorder, Entrapment, Painful Bladder Syndrome, Dehydration, Gigantism, Tumor-Associated Vasculature and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine

MeSH term MeSH ID Detail
Adenocarcinoma D000230 166 associated lipids
Lung Neoplasms D008175 171 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Body Weight D001835 333 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Melanoma D008545 69 associated lipids
Carcinoma, Ductal, Breast D018270 19 associated lipids
Hepatoblastoma D018197 10 associated lipids
Mammary Neoplasms, Animal D015674 27 associated lipids
Lymphoma, B-Cell D016393 24 associated lipids
Total 10

PubChem Associated disorders and diseases

What pathways are associated with 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine

Download all related citations
Per page 10 20 50 100 | Total 255
Authors Title Published Journal PubMed Link
Reddy TL et al. Simultaneous delivery of Paclitaxel and Bcl-2 siRNA via pH-Sensitive liposomal nanocarrier for the synergistic treatment of melanoma. 2016 Sci Rep pmid:27786239
Zetterberg MM et al. Optimization of lipodisk properties by modification of the extent and density of the PEG corona. 2016 J Colloid Interface Sci pmid:27592189
Lechanteur A et al. PEGylation of lipoplexes: The right balance between cytotoxicity and siRNA effectiveness. 2016 Eur J Pharm Sci pmid:27593989
Yu MZ et al. Systemic delivery of siRNA by T7 peptide modified core-shell nanoparticles for targeted therapy of breast cancer. 2016 Eur J Pharm Sci pmid:27355138
Patil Y et al. Targeting of pegylated liposomal mitomycin-C prodrug to the folate receptor of cancer cells: Intracellular activation and enhanced cytotoxicity. 2016 J Control Release pmid:26809007
Moosavian SA et al. Improvement in the drug delivery and anti-tumor efficacy of PEGylated liposomal doxorubicin by targeting RNA aptamers in mice bearing breast tumor model. 2016 Colloids Surf B Biointerfaces pmid:26722819
Cheng Y et al. Development, Optimization, and Characterization of PEGylated Nanoemulsion of Prostaglandin E1 for Long Circulation. 2016 AAPS PharmSciTech pmid:26195071
Xu Y and Meng H Paclitaxel-loaded stealth liposomes: Development, characterization, pharmacokinetics, and biodistribution. 2016 Artif Cells Nanomed Biotechnol pmid:25162671
Bansal D et al. Lactobionic acid coupled liposomes: an innovative strategy for targeting hepatocellular carcinoma. 2016 Drug Deliv pmid:24786484
Wang DD et al. Reiterated Targeting Peptides on the Nanoparticle Surface Significantly Promote Targeted Vascular Endothelial Growth Factor Gene Delivery to Stem Cells. 2015 Biomacromolecules pmid:26588028